is semaglutide controlled substance Semaglutide, a GLP-1 weight loss drug, slowed biological aging across multiple epigenetic clocks in a randomized, double-blind, placebo-controlled clinical trial in patients with HIV, suggesting that the drug may influence aging-related biology Semaglutide | DirectMeds

Although the overall risk is low, it is a significant concern

Its important to note that GLP-1s side effects are mild, and you might experience temporary symptoms such as diarrhea, nausea, vomiting, and constipation

Conclusion Administration of GLP-1RAs in patients with T2D achieved multiple clinical and metabolic benefits, nevertheless, cholelithiasis was more frequent among patients with GLP-1RAs that should be addressed frequently

GLP-1 ONLY $549 (3-MONTH PROGRAM) + $50 gift card Fill out the form and claim your Discount Service Coupon

Ozempic is FDA-approved for type 2 diabetes and certain cardiovascular risk reductions, not for obesity treatment